Table 1.
Comparative analysis of DAT positive and negative CLL patients (n = 58)
| Variables | DAT negative | DAT positive | p-value |
|---|---|---|---|
| No. of cases | n = 42 (Total = 58) | n = 16 (Total = 58) | |
| Percentage out of total cases | 72.4% | 27.5% | |
| Age > 65 years | 24 (57.1%) | 12 (75%) | 0.671 |
| Sex: M/F | 32/10 | 10/6 | 0.646 |
| Hb < 11 g/dL | 30 (71.4%) | 16 (100%) | 0.148 |
| TLC > 50 × 109/L | 16 (38.1%) | 8 (50%) | 0.683 |
| ALC > 30 × 109/L | 24 (57.1%) | 10 (62.5%) | 1.000 |
| PLT < 100 × 109/L | 14 (33.3%) | 10 (62.5%) | 0.218 |
| Lymphadenopathy | 14 (33.3%) | 2 (12.5%) | 0.381 |
| Splenomegaly | 8 (19.0%) | 2 (12.5%) | 1.000 |
| CD 38 | 4 (9.5%) | 10 (62.5%) | 0.008* |
| Rai 0 | 20 (47.6%) | 0 | 0.024* |
| I/II | 8 (19.0%) | 2 (12.5%) | |
| III/IV | 14 (33.3%) | 14 (87.5%) | |
| Binet A | 28 (66.6%) | 2 (12.5%) | 0.014* |
| C | 14 (33.3%) | 14 (87.5%) |
Hemoglobin (Hb), Total Leucocyte Count (TLC), Platelet Count (PLT), Absolute Lymphocyte Count (ALC), Male (M), Female (F), Cluster of differentiation (CD).
*
P value less than 0.05 was significant.